These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15123033)

  • 1. How is clinical progress achieved?
    Klareskog L; Lindblad S
    Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):1-5. PubMed ID: 15123033
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of adherence and chronic rheumatic disease in children and adolescents.
    Rapoff MA
    Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):301-14. PubMed ID: 16546058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain by name, pain by nature.
    Lipsky PE; Buckland J
    Nat Rev Rheumatol; 2010 Apr; 6(4):179-80. PubMed ID: 20357783
    [No Abstract]   [Full Text] [Related]  

  • 4. Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model.
    Wolfe F; Caplan L; Michaud K
    J Rheumatol; 2004 Dec; 31(12):2317-9. PubMed ID: 15570626
    [No Abstract]   [Full Text] [Related]  

  • 5. Spondylarthropathies in children--are they different from those in adults?
    Hofer M
    Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):315-28. PubMed ID: 16546059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of synovial arthritis].
    Duodecim; 2004; 120(7):833-4. PubMed ID: 15154303
    [No Abstract]   [Full Text] [Related]  

  • 7. Controversies in the treatment of osteoarthritis.
    Bird HA
    Clin Rheumatol; 2003 Sep; 22(3):165-7. PubMed ID: 14505204
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimisation of assessment for rheumatic diseases in clinical trials, observational studies and routine clinical care.
    Pincus T; Braun J; Kavanaugh A; Smolen JS
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-1. PubMed ID: 25365080
    [No Abstract]   [Full Text] [Related]  

  • 9. Are better endpoints and better design of clinical trials needed?
    Fransen J; van Riel PL
    Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):97-109. PubMed ID: 15123040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The randomized clinical trial of doxycycline in knee osteoarthritis: comment on the editorial by Dieppe.
    Brandt KD; Mazzuca SA
    Arthritis Rheum; 2006 Feb; 54(2):684. PubMed ID: 16447250
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tolerance of anti-TNF alpha: the experience acquired in inflammatory rheumatic disease].
    Mariette X
    Ann Dermatol Venereol; 2006 May; 133(5 Pt 2):1S8-12. PubMed ID: 16967603
    [No Abstract]   [Full Text] [Related]  

  • 12. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
    Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
    Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.
    Bayry J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Nat Clin Pract Rheumatol; 2007 May; 3(5):262-72. PubMed ID: 17471245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is minimal clinically important difference relevant for the interpretation of clinical trials in pediatric rheumatic diseases?
    Ruperto N
    J Rheumatol; 2007 Mar; 34(3):463-5. PubMed ID: 17343299
    [No Abstract]   [Full Text] [Related]  

  • 15. Juvenile spondyloarthropathies: inflammation in disguise.
    Akin E
    Minn Med; 2009 Sep; 92(9):45-7. PubMed ID: 19877479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in rheumatologic disease: a review.
    Whitt I; Reed A
    Minn Med; 2009 Sep; 92(9):38-41. PubMed ID: 19877477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myoblast transplantation for heart failure: where are we heading?
    Alfieri O; Livi U; Martinelli L; Arpesella G; Valfrè C; Lapenna E; Desnos M; Hagège AA; Menasché P
    Ital Heart J; 2005 Apr; 6(4):284-8. PubMed ID: 15902926
    [No Abstract]   [Full Text] [Related]  

  • 18. Trials are short, disease long: measuring drug utility beyond clinical trials.
    Luggen ML
    J Rheumatol; 2004 Feb; 31(2):205-6. PubMed ID: 14760785
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.
    Sonabend AM; Dana K; Lesniak MS
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S45-50. PubMed ID: 18076318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principles of management of musculoskeletal conditions in children and young people.
    Davis PJ; McDonagh JE
    Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):263-78. PubMed ID: 16546056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.